Samil Pharm Free Cash Flow Generation Index
Samil Pharm free cash flow generation index. Samil Pharm (000520) has a Free Cash Flow Generation Index of -0.33x as of June 2025. Free cash flow of ₩-814.57 Million represents 0% of operating cash flow (₩2.44 Billion). Check financial resilience of Samil Pharm to evaluate the company's liquid asset resilience ratio.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Free Cash Flow Generation Index of Samil Pharm (2012–2024)
Free cash flow generation index of Samil Pharm from 2012 to 2024. Historical FCF Generation Index trend for Samil Pharm across 10 annual periods. Explore 000520 capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
Samil Pharm Free Cash Flow Generation Index by Year (2012–2024)
Samil Pharm free cash flow generation index by year from 2012 to 2024. Year-by-year Free Cash Flow Generation Index for Samil Pharm. For the full cash flow conversion analysis, see how efficiently does Samil Pharm generate cash.
| Year | FCG Index | Free Cash Flow (KRW) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | -1.17x | ₩-3.02 Billion | ₩2.59 Billion | ₩5.61 Billion | ▼ -8.4% |
| 2023 | -1.08x | ₩-12.65 Billion | ₩11.75 Billion | ₩24.39 Billion | ▲ +90.0% |
| 2022 | -10.71x | ₩-44.50 Billion | ₩4.15 Billion | ₩48.48 Billion | ▲ +52.1% |
| 2021 | -22.35x | ₩-31.67 Billion | ₩1.42 Billion | ₩32.83 Billion | ▼ -1741.9% |
| 2020 | -1.21x | ₩-9.44 Billion | ₩7.77 Billion | ₩17.02 Billion | ▼ -230.4% |
| 2019 | -0.37x | ₩-3.89 Billion | ₩10.59 Billion | ₩13.89 Billion | ▲ +96.5% |
| 2017 | -10.43x | ₩-39.55 Billion | ₩3.79 Billion | ₩36.33 Billion | ▼ -682.6% |
| 2016 | 1.79x | ₩10.09 Billion | ₩5.63 Billion | ₩4.45 Billion | ▼ -0.9% |
| 2015 | 1.81x | ₩5.28 Billion | ₩2.92 Billion | ₩2.36 Billion | ▲ +31.0% |
| 2012 | 1.38x | ₩6.93 Billion | ₩5.02 Billion | ₩1.91 Billion | — |